Posts tagged “Biotech & Life Science”
The 2015 BioMarine international conference kicked off in Wilmington Monday evening with a well-attended invite-only networking event aboard the Battleship North Carolina, moored across the Cape Fear River from downtown Wilmington. Refreshments included an array of sustainably produced North Carolina seafood products and local craft beers, as well as the ubiquitous NC barbecue and cornbread. The Marine Bio-Technologies Center of Innovation and the North Carolina Biotechnology Center co-hosted the event.
North Carolina has been seeing a lot of recent rewards for its long-term investment in the life sciences. The recently released CED Innovators Report shows life science companies nailed down more than $268 million in equity investment in the first half of 2015.
Biogen donates RTP made meds; Sunlight matches ads to users, Symphony nabs $100M; Twitter slashing workforce
In today's Bulldog Update of technology news: Biogen donates hemophilia medicines made in RTP to Africa; new tool expands tracking of personal data online; Google part of $100M raise by messaging startup Symphony. Twitter is cutting jobs.
GROWERS, a Raleigh-based precision farm management business, says it is the first company to use the On-the-Go Organic Mapping Sensor, using GPS to locate each data point. Organic matter is directly related to a soil's yield capacity, so the ability to map this attribute is highly beneficial for farmers, the company explains.
The BioMarine Convention of company leaders, investors, and government leaders focused on business deal-making in the diverse marine biotech market space is set to start at the Southeastern North Carolina Biotechnology Center Tuesday and Wednesday.
Heat Biologics (Nasdaq:HTBX), a clinical-stage cancer immunotherapy company, said that it has completed enrollment of the full 75 patients in the blinded, randomized, placebo-controlled arms of the Phase 2 clinical trial of its drug for the treatment of high-risk, non-muscle invasive bladder cancer. Heat shares saw its shares gain a moderate rise on the news.
Scientists at Duke Medicine are using transparent fish to watch in real time as Cryptococcal meningitis takes over the brain. The resulting images are worthy of a sci-fi movie teaser, but could be valuable in disrupting the real, crippling brain infection that kills more than 600,000 people worldwide each year.
Carolina Liquid Chemistries (CLC), a Winston-Salem company that makes laboratory diagnostics and testing systems, has received FDA clearance to sell its latest state-of-the-art chemistry analyzer for hospital and clinical use.
Ohio-based AtriCure Inc. (Nasdaq:ATRC) has agreed to acquire Morrisville-based nContact Inc., a developer of innovative cardiac ablation solutions in a deal worth almost $150 million. Both companies are developing treatments for atrial fibrillation (Afib), a serious heart rhythm disorder.
In today's Bulldog Update of technology stories: life science industry fuels hot Triangle real estate market; Startup Grind to host David Garner of Cofounders Capital; NC CEO Forum set for November; Sprint layoffs likely.
A UNC Lineberger Comprehensive Cancer Center researcher is working to fight a growing type of head and neck cancer by partnering with a California company to develop a rapid oral test for HPV, a virus linked to cancer.
Joseph M. DeSimone, chancellor's eminent professor of Chemistry at the University of North Carolina at Chapel Hill, has been named the recipient of the inaugural $250,000 Kabiller Prize in Nanoscience and Nanomedicine. He won for his invention and use of PRINT, a breakthrough technology that has been used to make advances toward the development of new cancer treatments, inhalable therapeutics and next generation vaccines for malaria, pneumonia and dengue.
Ninety venture-backed M&A deals were reported in the third quarter, 20 of which had an aggregate deal value of $5.1 billion, increasing 39 percent compared to the second quarter and marking the strongest quarter for M&A exits this year, according to the Exit Poll Report by Thomson Reuters and the National Venture Capital Association (NVCA). Biotech companies accounted for more than three-quarters of the IPOS.
Welcome home, Icagen. Well, actually, the Durham drug development company never completely left, but now its once-relocated headquarters is returning to North Carolina from the Boston area with one relocating employee, bringing the head count at its Emperor Boulevard site to 20.